Atrial fibrillation leads to stroke, heart failure, sudden death and other health problems for millions worldwide. Yet, despite decades of research, many aspects of AFib care — from diagnosis to treatment — remain outdated.

Dr. Jeffrey Goldberger joined Inside U Miami Medicine to share how he is improving decades-old models to save lives.

“I saw two patients in the office within one month of each other. They had no risk factors. They had no hypertension. They had no significant cardiac disease. And they both had strokes,” he said.

He knew the field needed to evolve.

Prostate cancer affects more than half of males by age 80. Yet, early intervention can lead to complications that profoundly reduce quality of life. In the latest episode of “Inside U Miami Medicine,” luminaries in the field of urology mull over the complex question: Does every prostate cancer diagnosis require immediate treatment?

Dr. Ian Thompson, professor emeritus at the University of Texas Health Science Center San Antonio, has spent his career studying this conundrum. During this episode, he discusses seminal findings in large-scale trials that showed invasive treatments are associated with substantial, potentially life threatening conditions.

“What took my breath away was the rate of bladder cancer after radiation,” Dr. Thompson said. “A threefold increased risk of bladder cancer…”

Dr. Dipen Parekh, founding director of the Desai Sethi Urology Institute and chief operating officer for UHealth–University of Miami Health System, also joins the conversation.

The field of radiology is in flux, shifting with wave after wave of advanced technology. While the public speculated whether artificial intelligence (AI) might render radiologists obsolete, the experts were already harnessing its power to optimize workflows, alleviate burnout, improve patient care, and redefine their role within the health care team.

At the forefront of this transformation is Dr. Alexander McKinney, Shapiro professor and chair of the Department of Radiology at the University of Miami Miller School of Medicine. He joined us to share his excitement about the incredible potential of AI in radiology.

The world of migraine is complex and often misunderstood, even though it’s one the most disabling neurologic disorders in the world. Despite its prevalence, this common disease remains deeply stigmatized.

Teshamae Monteith, M.D., a nationally recognized headache expert, sheds light on groundbreaking research, pharmaceutical innovations and emerging treatments that aim to reshape the way we think about and treat migraine.

Prostate cancer is the 2nd most common cause of cancer death in U.S. men. While initial treatments offer hope, many patients find that their cancer returns with often fatal outcomes. But what if the key to stopping this deadly progression lies in our genes?

Dr. Nima Sharifi, scientific director of the Desai Sethi Urology Institute, discovered a specific genetic variant that enables tumors to bypass treatments, effectively producing their own hormones to fuel cancer growth.

Tune in!

Dr. David Davis, is breaking new ground in understanding how toxins, especially microplastics, may contribute to neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's.

In this episode of Inside U Miami Medicine, Dr. Davis shares his journey and the groundbreaking methodologies he developed to detect and study these toxins. From cyanobacterial blooms to airborne plastic particles, he reveals the urgent need to address these environmental threats.

We’re exploring visionary breakthroughs in the field of ophthalmology with Eduardo Alfonso, M.D., director of Bascom Palmer Eye Institute. Dr. Alfonso has his sight set on an ambitious project - whole eye transplant. He and his team are currently exploring the use of an ECMO device to preserve a donated eye, enabling them to apply gene therapy and stem cells, replace specific parts of the organ, and enhance its functionality.

Tune in to hear more about this fascinating venture, as well as other breakthroughs and challenges in the field that are providing new avenues for disease modeling, drug screening and cellular therapies.

Dr. Helen Bermudez, a gastroenterology fellow, overcame immense challenges to pursue her dream. Born in Cuba, she immigrated to the U.S. at age 15. She spoke no English but carried an unwavering dedication to help others through medicine. Tune in as we explore Dr. Bermudez’s story of resilience and the advice she offers others facing similar paths.